CAFC Updates

UCB owns U.S. Patent Nos. 6,884,434 and 8,232,414, claiming a transdermal therapeutic system comprising rotigotine, a drug used for the treatment...

Mayne Pharma appeals from the final written decision of the U.S. Patent and Trademark Office Patent Trial and Appeal Board (“the Board”) in...

Flow Valve’s U.S. Patent No. RE45,878 relates to supporting assemblies, i.e., fixtures, for holding workpieces (such as pipe fittings used in...

The Regents of the University of Minnesota appeals from decisions by the Patent Trial and Appeal Board declining to dismiss petitions for inter partes review...

Semiconductor Components, doing business as ON Semiconductor (“ON”), petitioned for inter partes review (“IPR”) of several claims of Power Integrations’ U.S. Patent No. 6,212,079 relating...

Samsung successfully petitioned the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office to institute an inter partes review (IPR)...

Quest appeals a judgment of the District Court in favor of Cokebusters holding on summary judgment that claims of U.S. Patent No. 7,542,874...

Nuvo sued three Generics manufacturers (Dr. Reddy’s Laboratories, Mylan Pharmaceuticals, and Lupin Pharmaceuticals) to prevent their ANDA products from going to market, if...

BTG sued Amneal Pharmaceuticals, asserting that Amneal’s Abbreviated New Drug Applications (“ANDA”) for the generic version of BTG’s abiraterone product ZYTIGA® infringes U.S. Patent...

Bradium Technologies LLC appealed final written decisions of the Patent Trial and Appeal Board finding the claims of U.S. Patent Nos. 7,908,343 and 8,924,506...